Receiving the designation as Innovation Champion is a validation of our mission to change the way drugs are priced and administered, and it represents the broad support across the country to transform the antiquated and opaque pricing model for prescription drugs.
This month's industry round-up features news Babylon has been shortlisted for a $100m MacArthur grant and a London uni is using VR to spot sepsis.